ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
After failing to secure a steady stream of funding, the Myelin Repair Foundation is shutting its doors. The nonprofit was formed in 2003 with the goal of developing drugs to repair myelin, the nerve-cell insulating layer that is damaged in people with multiple sclerosis. MRF had for years worked to generate tools and technologies for use in myelin drug discovery. In 2012, it set up labs and hired a small team of scientists to translate early research into drug candidates. MRF is now trying to wrap up experiments, find a home for assays, and find a way to maintain its network of collaborations.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X